Table 3:

Association of H2/PPI use with diagnosis of ocular toxoplasmosis for the sensitivity analysis

	Control	Case	aOR (95% CI)*	P value
A prescription for PPI/H2 blocker	4557 (19.6%)	1199 (24.3%)	1.23 (1.13, 1.33)	<0.001
A prescription for PPI/H2 blocker OR hx of disease that would be likely to lead to use of PPI/H2 blocker	8152 (35.0%)	1997 (40.5%)	1.19 (1.11, 1.28)	<0.001

^*Conditional logistic regression adjusting for age, education, income, geographic location, hypertension, hypercholesterolemia, Ischemic heart disease, Heart failure, Diabetes Mellitus, Alcohol Abuse, Smoking, Pregnancy in the 2 years prior to index date, NSAID use in the 2 years prior to the index date and oral steroid use in the 2 years prior to the index date

aOR, adjusted odds ratio; CI, confidence interval; H2, histamine; hx, history; PPI, proton pump inhibitor